FDA cautions against the use of Polyfort Suspension after recall in Nigeria

The (FDA) has issued a warning to the Ghanaian public about the use of Polyfort Suspension following its recall in .

Polyfort Suspension, an antacid used to treat heartburn, indigestion and hyperacidity, is manufactured in Nigeria by Swiss Pharma Limited.

According to a statement by the FDA, the recall was due to negative results from a series of ongoing stability tests.

The statement further noted that the FDA Ghana had not registered the product, and urged anyone who came across it in trade in Ghana to report to any of the FDA's offices across the country.

The FDA's surveillance team was also actively monitoring the country's ports of entry and markets to ensure that such unregistered products were not available in the country.

In addition, the FDA advised the public to check the registration status of regulated products on the FDA website, http://fdaghana.gov.gh, or through the ProPer platform – https://bit.ly/ProPerFDA before purchase.

The public can also contact the FDA on any of its contacts on 0551112224/05551112225 on WhatsApp 0551112224 for further information.

Leave a Reply

Your email address will not be published.